Ana Maria Rivas-Grajales, MD, MSc
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Psychiatry

MD, Universidad Del Valle
MSc, University College London (UCL)



Dr. Ana Maria Rivas-Grajales is a neuropsychiatrist and Assistant Professor in the Department of Psychiatry at Boston University Chobanian & Avedisian School of Medicine. She serves as Director of Neuropsychiatry and Neuromodulation and as Director of the Transcranial Magnetic Stimulation (TMS) Clinic at Boston Medical Center, where she provides specialized care for patients with major depressive disorder.

Dr. Rivas-Grajales completed her residency training in psychiatry at Baylor College of Medicine, followed by a clinical fellowship in Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital. Her clinical expertise includes the neuropsychiatric complications of movement disorders, dementia, epilepsy, and functional neurological disorder, as well as psychiatric presurgical evaluations for patients undergoing surgical or device-based interventions for epilepsy and movement disorders.

Her research focuses on elucidating the mechanisms of action of neuromodulation therapies for treatment-resistant depression and on identifying clinical and neuroimaging biomarkers of rapid-acting antidepressant treatments.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Rivas-Grajales AM, Mouradian P, Papadimitriou G, Lee E, Kubicki M, Makris N, Camprodon JA. Electroconvulsive therapy is associated with a decrease in anhedonia and axial diffusivity in the medial forebrain bundle in major depressive disorder. J Affect Disord. 2026 Apr 15; 399:120890. PMID: 41448396; DOI: 10.1016/j.jad.2025.120890;
     
  2. Rivas-Grajales AM, Han SC, Wang R, Greenstein P, Shih LC. L266V MAPT Gene Mutation Associated With Frontotemporal Dementia, Progressive Supranuclear Palsy, and Corticobasal Syndrome. J Neuropsychiatry Clin Neurosci. 2025; 37(3):274-278. PMID: 39789940; DOI: 10.1176/appi.neuropsych.20240128;
     
  3. Rivas JC, Galindo-A J, Zambrano LF, Miranda-B CA, Ramírez SM, Rivas-Grajales AM, Hernández-Carrillo M, Rincón EA, Perafán PE, Gómez-Mesa JE. Risk of corrected QT interval prolongation in patients receiving antipsychotics. Int Clin Psychopharmacol. 2025 Jul 01; 40(4):207-213. PMID: 39082114; DOI: 10.1097/YIC.0000000000000564;
     
  4. Tanev KS, Camprodon JA, Caplan DN, Dickerson BC, Chemali Z, Eldaief MC, Kim DD, Josephy-Hernandez SE, Kritzer MD, Moo LR, Newhouse A, Perez DL, Ramirez Gomez LA, Razafsha M, Rivas-Grajales AM, Scharf JM, Schmahmann JD, Sherman JC. Telemedicine-Based Cognitive Examinations During COVID-19 and Beyond: Perspective of the Massachusetts General Hospital Behavioral Neurology & Neuropsychiatry Group. J Neuropsychiatry Clin Neurosci. 2024; 36(2):87-100. PMID: 38111331
     
  5. Rivas-Grajales AM, Barbour T, Camprodon JA, Kritzer MD. The Impact of Sex Hormones on Transcranial Magnetic Stimulation Measures of Cortical Excitability: A Systematic Review and Considerations for Clinical Practice. Harv Rev Psychiatry. 2023 May-Jun 01; 31(3):114-123. PMID: 37171472; PMCID: PMC10264142; DOI: 10.1097/HRP.0000000000000366;
     
  6. Carreon RL, Rivas-Grajales AM, Murphy N, Mathew SJ, Jha MK. Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics. Adv Neurobiol. 2023; 30:287-297. PMID: 36928855
     
  7. Molton IR, Keatley E, Jaywant A, Josephy-Hernandez S, Rivas-Grajales AM, Perez DL, Mukherjee D. Ethical issues in the treatment of functional neurological disorder. PM R. 2022 01; 14(1):112-119. PMID: 34958180
     
  8. Rivas-Grajales AM, Mathew SJ, Rodgers JJ. A Case of Intranasal Ketamine Misuse: Considerations for Clinical Practice. J Psychiatr Pract. 2021 11 05; 27(6):492-495. PMID: 34768275
     
  9. Rivas-Grajales AM, Salas R, Robinson ME, Qi K, Murrough JW, Mathew SJ. Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression. Int J Neuropsychopharmacol. 2021 05 18; 24(5):383-391. PMID: 33249434; PMCID: PMC8130203; DOI: 10.1093/ijnp/pyaa089;
     
  10. Schanzer B, Rivas-Grajales AM, Khan A, Mathew SJ. Novel investigational therapeutics for generalized anxiety disorder (GAD). Expert Opin Investig Drugs. 2019 Nov; 28(11):1003-1012. PMID: 31607187
     
Showing 10 of 15 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 15 publications over 8 distinct years, with a maximum of 3 publications in 2019 and 2023

YearPublications
20161
20182
20193
20212
20221
20233
20241
20252


2021 Society of Biological Psychiatry: Domestic Travel Fellowship Awared
2021 Baylor College of Medicine: Christopher D. Martin Resident Excellence Award
2021 Baylor College of Medicine: Resident Research Award
2021 Baylor College of Medicine: Eugen Kahn Award for Excellence in Psychiatry
2020 Baylor College of Medicine: Women of Excellence Award
2020 National Neuroscience Curriculum Initiative: National Neuroscience Curriculum Initiative Scholar Award
2019 National Institute of Mental Health: NIMH Outstanding Resident Award Program
2019 American Psychiatric Association: APA Research Colloquium Junior Investigator Award
2019 American Academy of Addiction Psychiatry: Resident Travel Scholarship
2014 Colfuturo-Colciencias: Colfuturo Scholarship for MSc Studies
2014 University College London: Part-fund Scholarship for MSc studies
2013 Universidad del Valle: Dean’s Honored Graduate
Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map

617.414.1932
Download vCard

Rivas-Grajales's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (68) concept(s)
_
Co-Authors
See all (1) people
_
Similar People
See all (60) people
_
Same Department
Search Department